Wing Tech Inc.

Industry / private company


Location: Irvine, CA, United States (USA) (US) US

ISNI: -

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence (2024) Sharp AS, Cao KN, Esler MD, Kandzari DE, Lobo MD, Schmieder R, Pietzsch JB Journal article Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry (2022) Schmieder R, Mahfoud F, Mancia G, Narkiewicz K, Ruilope L, Hutton D, Cao K, et al. Journal article CLINICAL EVENT REDUCTIONS IN HIGH-RISK HYPERTENSION PATIENTS TREATED WITH RENAL DENERVATION: 10-YEAR PROJECTIONS BASED ON 3-YEAR FOLLOW-UP FROM THE GLOBAL SYMPLICITY REGISTRY (2022) Esler M, Cao K, Lobo M, Sharp ASP, Kandzari DE, Mancia G, Bohm M, et al. Conference contribution 10-YEAR CLINICAL EVENTS AVOIDED IN DIABETIC AND CHRONIC KIDNEY DISEASE HYPERTENSION PATIENTS TREATED WITH RADIOFREQUENCY RENAL DENERVATION: PROJECTIONS BASED ON 3-YEAR DATA FROM THE GLOBAL SYMPLICITY REGISTRY (2022) Schmieder R, Cao K, Esler M, Kandzari D, Lobo M, Sharp A, Mancia G, et al. Conference contribution Reduction of Clinical Events in High-Risk Hypertension Patients Treated With Renal Denervation: A Modeled Estimate From 36-Month Global SYMPLICTY Registry Data (2022) Schlaich M, Pietzsch JB, Mahfoud F, Wiliams B, Mancia G, Narkiewicz K, Ruilope L, et al. Conference contribution COST-EFFECTIVENESS ANALYSIS OF NEXT GENERATION RENAL DENERVATION THERAPY DEVICES: THRESHOLD ANALYSIS AND PROJECTIONS OF THE SPYRAL HTN-ON MED TRIAL FOR GERMANY (2018) Pietzsch JB, Geisler BP, Schmieder R Conference contribution